Found 155 matching trials
A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection PHASE3 To compare the impact on recurrence risk of adjuvant Sintilimab (a recombin...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Perioperative Therapy for Hepatocellular Carcinoma PHASE2 This study aims to observe and evaluate the efficacy and safety of the peri...
Show More Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Safety and Efficacy of Leucine-Restricted Diet Combined With Neoadjuvant Chemotherapy and Immunotherapy in Gastric Cancer PHASE2 Consistent with previous literature, the investigators postulate that a leu...
Show More Location
Qilu Hospital of Shandong University
Learn More & Join Trial
The Clinical Significance of Peripheral Blood T Lymphocyte PD-1 Expression and T Cell Subset Distribution. PHASE2 Providing more theoretical basis for the prediction of the efficacy of adva...
Show More Location
Department of Medical Oncology, Central Hospital of Yichang City, the First Clinical Medical College of Three Gorges University
Learn More & Join Trial
A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma. PHASE2 Recently, a number of clinical studies were carried out to evaluate the the...
Show More Location
Multiple Locations
Learn More & Join Trial
BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL PHASE3 This is a randomized, open-label, prospective, multicenter phase III superi...
Show More Location
Fudan University Shanghai Cancer Center,
Learn More & Join Trial
Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma PHASE1 This study is designed to evaluate the efficacy and safety of sintilimab-be...
Show More Location
Multiple Locations
Learn More & Join Trial
Sintilimab Versus Pembrolizumab for Advanced-stage Non-Small-Cell Lung Cancer PHASE2 This study is a single-center, randomized controlled, phase II clinical tri...
Show More Location
Multiple Locations
Learn More & Join Trial
Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial PHASE3 This is a randomized, controlled clinical trial based on prior exploratory ...
Show More Location
Guangdong Provincial People's Hospital
Learn More & Join Trial
Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients PHASE1 This pilot phase I trial aims to investigate the safety and tolerability of...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial